2007
DOI: 10.1016/j.ctrv.2007.01.005
|View full text |Cite
|
Sign up to set email alerts
|

Impact of antioxidant supplementation on chemotherapeutic efficacy: A systematic review of the evidence from randomized controlled trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
130
0
7

Year Published

2008
2008
2019
2019

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 202 publications
(141 citation statements)
references
References 41 publications
4
130
0
7
Order By: Relevance
“…33 In comparison with palifermin, NAC is relatively inexpensive and has no considerable interactions with antineoplastic drugs. [34][35][36][37] In our study, the overall duration of OM was also significantly shorter in the NAC group whereas in Jahangard-Rafsanjani et al 9 study, only the mean duration of severe OM (grade 3-4) was significantly lower in the intervention group (selenium). However, none of the agents could alter time to onset of OM.…”
Section: Discussionmentioning
confidence: 70%
“…33 In comparison with palifermin, NAC is relatively inexpensive and has no considerable interactions with antineoplastic drugs. [34][35][36][37] In our study, the overall duration of OM was also significantly shorter in the NAC group whereas in Jahangard-Rafsanjani et al 9 study, only the mean duration of severe OM (grade 3-4) was significantly lower in the intervention group (selenium). However, none of the agents could alter time to onset of OM.…”
Section: Discussionmentioning
confidence: 70%
“…Alternatively, there remains considerable controversy as to whether antioxidants may also reduce the tumoricidal effects of chemotherapy that act as strong oxidants. 5,6 In this regard, Weiss et al 36 have recently reported that NAC administered for 10 days after allo-SCT to BALB/c mice led to a mild reduction in graft-versus-leukemia.…”
Section: Discussionmentioning
confidence: 99%
“…Some have antitumor activity and others may enhance the effect of other anticancer treatments. 3,5,6 Despite a great number of reported studies, an excellent review by Malmberg 5 and a meta-analysis by Block et al 6 point out that their ability to enhance tumor killing is variable and that the loss of host immune response to tumor antigens is a potential drawback. In this regard, there are very few agents that have proven clinically effective in reducing normal tissue injury induced by IR and cytoreductive chemotherapy.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The present study suggests that, Raphnus sativus partial purified protein with SOD-like activity may be one of the treatment strategies. Ben Salah-Abbès, reported that, the extract of radishcontains many antioxidant compounds that protect against the toxicity resulting from mycotoxin (Zearalenone) [36] [37].…”
Section: Discussionmentioning
confidence: 99%